Third Harmonic Bio, Inc.
THRD · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $48 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $12 |
| Gross Profit | -$13 | $24 | -$12 | -$12 |
| % Margin | – | 50% | – | – |
| R&D Expenses | $10,645 | $10,537 | $11,343 | $8,394 |
| G&A Expenses | $8,071 | $5,902 | $5,730 | $5,676 |
| SG&A Expenses | $8,071 | $5,902 | $5,730 | $5,664 |
| Sales & Mktg Exp. | $0 | $0 | $0 | -$12 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $18,716 | $16,439 | $17,073 | $14,058 |
| Operating Income | -$18,716 | -$16,439 | -$17,073 | -$14,070 |
| % Margin | – | -34,247.9% | – | – |
| Other Income/Exp. Net | $2,882 | $3,332 | $3,274 | $3,363 |
| Pre-Tax Income | -$15,834 | -$13,107 | -$13,799 | -$10,707 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$15,834 | -$13,107 | -$13,799 | -$10,707 |
| % Margin | – | -27,306.3% | – | – |
| EPS | -0.35 | -0.29 | 0.33 | -0.26 |
| % Growth | -20.7% | -187.9% | 226.9% | – |
| EPS Diluted | -0.35 | -0.29 | 0.33 | -0.26 |
| Weighted Avg Shares Out | 44,917 | 41,318 | 41,318 | 40,556 |
| Weighted Avg Shares Out Dil | 44,917 | 41,318 | 41,318 | 40,556 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,888 | $3,334 | $3,278 | $3,364 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $13 | $13 | $12 | $12 |
| EBITDA | -$18,703 | -$16,426 | -$17,061 | -$14,058 |
| % Margin | – | -34,220.8% | – | – |